These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9456017)

  • 1. Cutaneous necrotizing vasculitis after low dose methotrexate therapy for rheumatoid arthritis: a possible manifestation of methotrexate hypersensitivity.
    Simonart T; Durez P; Margaux J; Van Geertruyden J; Goldschmidt D; Parent D
    Clin Rheumatol; 1997 Nov; 16(6):623-5. PubMed ID: 9456017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocytoclastic vasculitis induced by low-dose methotrexate: in vitro evidence for an immunologic mechanism.
    Halevy S; Giryes H; Avinoach I; Livni E; Sukenik S
    J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):81-5. PubMed ID: 9552765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate related cutaneous vasculitis.
    Torner O; Ruber C; Olive A; Tena X
    Clin Rheumatol; 1997 Jan; 16(1):108-9. PubMed ID: 9132315
    [No Abstract]   [Full Text] [Related]  

  • 4. Tocilizumab-induced leucocytoclastic vasculitis in a patient with rheumatoid arthritis.
    Sakaue S; Sumitomo S; Kubo K; Fujio K; Yamamoto K
    Rheumatology (Oxford); 2014 Aug; 53(8):1529-30. PubMed ID: 24609062
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nodular efflorescence and cutaneous vasculitis in rheumatoid arthritis treated with methotrexate].
    Lassoued S; Billey T; Pages M; Dromer C; Fournie B; Fournie A
    Presse Med; 1992 Mar; 21(9):437. PubMed ID: 1533038
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous vasculitis induced by TNF inhibitors: a report of three cases.
    Fujikawa K; Kawakami A; Hayashi T; Iwamoto N; Kawashiri SY; Aramaki T; Ichinose K; Tamai M; Arima K; Kamachi M; Yamasaki S; Nakamura H; Ida H; Origuchi T; Eguchi K
    Mod Rheumatol; 2010 Feb; 20(1):86-9. PubMed ID: 19812889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocytoclastic vasculitis due to etanercept.
    Galaria NA; Werth VP; Schumacher HR
    J Rheumatol; 2000 Aug; 27(8):2041-4. PubMed ID: 10955351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital vasculitis with eosinophilia possibly associated with etanercept therapy.
    Nakahigashi K; Egawa G; Miyachi Y; Kabashima K
    Acta Derm Venereol; 2014 Mar; 94(2):239-40. PubMed ID: 23824408
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous vasculitis associated with infliximab in the treatment of rheumatoid arthritis.
    Anandacoomarasamy A; Kannangara S; Barnsley L
    Intern Med J; 2005 Oct; 35(10):638-40. PubMed ID: 16207269
    [No Abstract]   [Full Text] [Related]  

  • 10. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
    Clemente RE
    Scand J Rheumatol; 2007; 36(3):244-5; author reply 245. PubMed ID: 17657687
    [No Abstract]   [Full Text] [Related]  

  • 11. Rituximab-induced vasculitis: A case report and review of the medical published work.
    Kim MJ; Kim HO; Kim HY; Park YM
    J Dermatol; 2009 May; 36(5):284-7. PubMed ID: 19382999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocytoclastic Vasculitis and Dermal Perivascular Hemophagocytosis Associated With Adalimumab Therapy for Rheumatoid Arthritis.
    Muto J; Usami J; Watanabe D
    Am J Dermatopathol; 2018 Jan; 40(1):57-59. PubMed ID: 28719435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
    Martínez-Taboada VM; Val-Bernal JF; Pesquera LC; Fernández-Llanio NE; Esteban JM; Blanco R; Alonso-Bartolome P; Gonzalez-Vela C; Rodríguez-Valverde V
    Scand J Rheumatol; 2006; 35(4):322-3. PubMed ID: 16882599
    [No Abstract]   [Full Text] [Related]  

  • 14. Atypical methotrexate dermatitis and vasculitis in a patient with ankylosing spondylitis.
    Borman P; Bodur H; Güleç AT; Uçan H; Seçkin U; Mocan G
    Rheumatol Int; 2000; 19(5):191-3. PubMed ID: 10984137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute febrile toxic reaction in patients with refractory rheumatoid arthritis who are receiving combined therapy with methotrexate and azathioprine.
    Blanco R; Martínez-Taboada VM; González-Gay MA; Armona J; Fernández-Sueiro JL; González-Vela MC; Rodríguez-Valverde V
    Arthritis Rheum; 1996 Jun; 39(6):1016-20. PubMed ID: 8651964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose methotrexate therapy for cutaneous vasculitis of rheumatoid arthritis.
    Upchurch KS; Heller K; Bress NM
    J Am Acad Dermatol; 1987 Aug; 17(2 Pt 2):355-9. PubMed ID: 3624579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated cutaneous nodulosis during methotrexate therapy in a patient with rheumatoid arthritis.
    Williams FM; Cohen PR; Arnett FC
    J Am Acad Dermatol; 1998 Aug; 39(2 Pt 2):359-62. PubMed ID: 9703153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of 453 rheumatoid arthritis patients treated with methotrexate: an open, retrospective, observational study.
    Bologna C; Viu P; Picot MC; Jorgensen C; Sany J
    Br J Rheumatol; 1997 May; 36(5):535-40. PubMed ID: 9189054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical methotrexate dermatitis in a patient with rheumatoid arthritis.
    Giordano N; Senesi M; Gennari C
    Clin Exp Rheumatol; 1996; 14(4):450. PubMed ID: 8871851
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary cutaneous B cell lymphoma during methotrexate therapy for rheumatoid arthritis.
    Fam AG; Perez-Ordonez B; Imrie K
    J Rheumatol; 2000 Jun; 27(6):1546-9. PubMed ID: 10852288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.